April 12, 2026
“Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico’s CEO, Alex Zhavoronkov, said Eli Lilly has a competitive edge in certain aspects of… Continue Reading…

Recent Comments